MDT · XBRL financial data

Medtronic financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (MDT's year ends in late April)

In millions of dollarsOct 27, 2023Jan 26, 2024Apr 26, 2024Jul 26, 2024Oct 25, 2024Jan 24, 2025Apr 25, 2025Jul 25, 2025Oct 24, 2025Jan 23, 2026Apr 24, 2026Jul 31, 2026
Revenue from contracts with customers7,9848,0898,589*7,9158,4038,2928,927*8,5788,9619,0179,807*9,756
Cost of goods and services sold2,7612,7823,044*2,7612,9462,7793,147*3,0013,0613,2613,398*3,416
Selling, general and administrative2,6862,6732,765*2,6552,7572,7172,720*2,8062,9652,9563,057*3,198
Other operating income (expense)31(17)(477)*(1)345(15)*(70)(22)(35)(260)*(123)
Operating income (loss)1,3401,4831,053*1,2781,5951,6461,436*1,4451,6861,4641,873*1,764
Interest income148170——————————
Interest expense180188202*167209179174*176181181176*186
Other income (expense)1541775*15717372(1)*3392121137*190
Income tax expense (benefit)402135197*220281237199*255215254575*289
Net income (loss)9091,322654*1,0421,2701,2941,056*1,0401,3741,1431,244*1,470
Earnings per share, basic USD per share0.680.990.50*0.810.991.010.82*0.811.070.890.97*1.15
Earnings per share, diluted USD per share0.680.990.49*0.800.991.010.82*0.811.070.890.97*1.14
Weighted average shares, basic millions of shares1,3301,3301,320*1,2931,2821,2821,284*1,2821,2821,2831,281*1,280
Weighted average shares, diluted millions of shares1,3321,3321,323*1,2971,2871,2861,290*1,2871,2881,2901,288*1,285

Balance sheet

CSV

Fiscal quarters (MDT's year ends in late April)

In millions of dollarsOct 27, 2023Jan 26, 2024Apr 26, 2024Jul 26, 2024Oct 25, 2024Jan 24, 2025Apr 25, 2025Jul 25, 2025Oct 24, 2025Jan 23, 2026Apr 24, 2026Jul 31, 2026
Cash and cash equivalents1,3111,6231,2841,3111,3941,2402,2181,2731,2821,1471,9491,691
Short-term investments6,4236,6986,7216,5326,5956,6826,7476,8487,0457,2367,2717,128
Accounts receivable5,9345,9686,1286,0116,2606,1156,5156,2636,3896,3596,6436,357
Inventory5,7545,7265,2175,4145,4795,6105,4765,8866,1566,3095,9516,215
Total current assets22,08122,51321,93521,94722,43822,51323,81423,22323,99624,07124,78724,390
Property and equipment, net5,7355,8386,1316,2826,4386,5936,8377,0067,1647,1797,4177,473
Right-of-use asset——1,012———1,100———1,197—
Goodwill40,82141,16040,98641,08441,16140,81941,73742,00741,81141,89242,58743,187
Total assets90,08790,83689,98189,74990,04289,97391,68090,97291,34691,48593,02893,306
Accounts payable2,1741,9922,4102,2912,3762,2862,4492,5552,5812,5692,6442,695
Commercial paper——1,073———0—————
Total current liabilities9,6599,79310,78910,28712,19511,84012,87911,5309,9359,49511,65811,799
Lease liability, non-current——840———918———989—
Total liabilities38,44038,84039,56141,58941,32640,35843,42442,83942,48942,28942,95642,456
Retained earnings30,25630,66130,40330,54730,91931,31731,47631,60632,07032,30332,63833,187
Total stockholders' equity51,46051,79250,21447,94748,49449,38748,02447,89348,65248,98549,46350,232
Total liabilities and equity90,08790,83689,98189,74990,04289,97391,68090,97291,34691,48593,02893,306
Common shares outstanding (cover page) millions of shares1,3301,3281,2821,2821,2821,2831,2811,2831,2821,2841,2801,279

Cash flows

CSV

Fiscal quarters (MDT's year ends in late April)

In millions of dollarsOct 27, 2023Jan 26, 2024Apr 26, 2024Jul 26, 2024Oct 25, 2024Jan 24, 2025Apr 25, 2025Jul 25, 2025Oct 24, 2025Jan 23, 2026Apr 24, 2026Jul 31, 2026
Net income (loss)9091,322654*1,0421,2701,2941,056*1,0401,3741,1431,244*1,470
Stock-based compensation146*84*90*83159*98*89*86182*94*95*125
Depreciation and amortization672*649*654*662675*684*840*748745*749*716*729
Net cash from operating activities661*2,474*2,777*986958*2,572*2,528*1,088925*2,744*2,573*1,793
Purchases of property and equipment461*346*426*520404*476*459*504468*444*488*503
Net cash from investing activities(424)*(707)*(696)*(259)(345)*(843)*(490)*(719)(482)*(816)*(917)*(1,619)
Proceeds from issuing common stock——year only———year only95——year only20
Proceeds from issuing equity72*57*78*89143*168*108*95160*164*——
Share repurchases226*132*1,628*2,492288*181*274*123372*105*435*267
Dividends paid918*917*913*898897*897*897*910910*911*908*921
Proceeds from long-term debt0*0*0*3,2090*0*0*01,747*0*0*—
Repayments of long-term debt0*0*0*00*0*0*1,1621,768*0*0*0
Net cash from financing activities(90)*(1,500)*(2,359)*(731)(534)*(1,753)*(1,343)*(1,381)(395)*(2,087)*(888)*(343)
Net change in cash(28)*312*(339)*2783*(154)*978*(945)9*(136)*803*(258)

Compare with peers

SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Medtronic1,6919,7561,7931.3B 10-QJul 31, 2026
Stryker3,2716,5201,461*380.7M 10-QSep 30, 2026
Boston Scientific6095,1381,048*1.4B 10-QSep 30, 2026
3M4,8356,584486*516.7M 10-QSep 30, 2026
Intuitive Surgical2,9783,0491,224*346.6M 10-QSep 30, 2026
Becton Dickinson7084,983not reported272.4M 10-QJun 30, 2026
Edwards Lifesciences2,9071,741652*576.4M 10-QJun 30, 2026
Resmed1,0111,415422140.7M 10-QSep 30, 2026
Dexcom9611,345326*373.0M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.